GKIM
RMD icon

GW&K Investment Management’s ResMed RMD Stock Holding History

GW&K Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
103
-1
-1% -$207 ﹤0.01% 796
2026
Q1 		$23K Sell
104
-6
-5% -$1.5K ﹤0.01% 734
2025
Q4 		$26K Buy
110
+4
+4% +$1.02K ﹤0.01% 692
2025
Q3 		$29K Hold
106
– – ﹤0.01% 649
2025
Q2 		$27K Buy
106
+2
+2% +$477 ﹤0.01% 636
2025
Q1 		$23K Hold
104
– – ﹤0.01% 624
2024
Q4 		$24K Buy
104
+2
+2% +$482 ﹤0.01% 586
2024
Q3 		$25K Buy
102
+19
+23% +$4.25K ﹤0.01% 573
2024
Q2 		$16K Buy
83
+7
+9% +$1.42K ﹤0.01% 612
2024
Q1 		$15K Buy
76
+2
+3% +$366 ﹤0.01% 590
2023
Q4 		$13K Buy
74
+30
+68% +$4.61K ﹤0.01% 612
2023
Q3 		$7K Buy
44
+2
+5% +$362 ﹤0.01% 727
2023
Q2 		$9K Buy
+42
New +$9.36K ﹤0.01% 645
2022
Q3 		– Sell
-17
Closed -$4K – 743
2022
Q2 		$4K Buy
17
+8
+89% +$1.7K ﹤0.01% 651
2022
Q1 		$2K Buy
+9
New +$2.18K ﹤0.01% 723
2014
Q4 		– Sell
-60,359
Closed -$2.97M – 222
2014
Q3 		$2.97M Sell
60,359
-27,929
-32% -$1.42M 0.08% 174
2014
Q2 		$4.47M Buy
88,288
+8,038
+10% +$398K 0.11% 163
2014
Q1 		$3.59M Buy
80,250
+6,847
+9% +$308K 0.1% 164
2013
Q4 		$3.46M Buy
73,403
+9,377
+15% +$475K 0.09% 154
2013
Q3 		$3.38M Buy
64,026
+2,630
+4% +$128K 0.1% 151
2013
Q2 		$2.77M Buy
+61,396
New +$2.91M 0.1% 151

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GW&K Investment Management's RMD Position: Q2 2026 in Review

GW&K Investment Management reduced its ResMed (RMD) stake by 0.96% in Q2 2026, selling an estimated $207 and leaving 103 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

GW&K Investment Management first reported a position in RMD in Q2 2013 and has held it in 21 quarters since. The position peaked at $4.47M in Q2 2014. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GW&K Investment Management held 103 shares of ResMed worth $20K as of Q2 2026.
  • GW&K Investment Management sold 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #796 holding.
  • GW&K Investment Management first reported a position in ResMed in Q2 2013 and has held it in 21 quarters since.
  • GW&K Investment Management's ResMed position peaked at $4.47M in Q2 2014.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.